OracleORCL

Business Snapshot

• Oracle Corp. (NYSE: ORCL) is a US-listed common stock trading in USD. The payload does not provide a sector or industry classification.
• Current pre-market price: $147.39; session range: $137.43–$153.99.
• The supplied financial data shows substantial revenue and operating-income growth across the reported periods, alongside a sharp increase in capital expenditures and increasingly negative free cash flow.
• Shares outstanding increased from 2.841 billion on 2025-08-31 to 2.880 billion on 2026-05-31, a net increase of approximately 39 million shares.

Financial Trends

• Revenue trajectory: Reported revenue rose from $14.926 billion on 2025-08-31 to $16.058 billion on 2025-11-30, up $1.132 billion or 7.6%. It increased again to $17.190 billion on 2026-02-28, up $1.132 billion or 7.0%. The latest 10-K reports $67.357 billion, but this is an annual figure and is not directly comparable with the quarterly amounts. On the comparable quarterly sequence, revenue growth was steady rather than decelerating.
• Operating income and margin: Operating income increased from $4.277 billion to $4.731 billion in the first comparison, a gain of $454 million or 10.6%, then to $5.464 billion, a gain of $733 million or 15.5%. Operating margin improved from 28.65% to 29.46%, then 31.79%, indicating operating leverage. The latest annual operating margin was 30.59%, below the immediately preceding quarterly figure but above the earliest reported quarter.
• Net income and net margin: Net income rose from $2.927 billion to $6.135 billion, then declined to $3.721 billion. The latest quarter-to-quarter change was a decrease of $2.414 billion, or 39.3%. Net margin moved from 19.61% to 38.21%, then down to 21.65%. The latest annual net margin was 25.37%. Net income therefore showed much greater volatility than operating income, with the 2025-11-30 period representing a high base.
• EPS trajectory: Diluted EPS increased from $1.01 to $2.10, then fell to $1.27. The latest annual diluted EPS was $5.83. The data does not provide enough detail to attribute the quarterly EPS volatility.
• Free cash flow: FCF deteriorated sharply from negative $362 million on 2025-08-31 to negative $10.329 billion on 2025-11-30, a decline of $9.967 billion. It worsened to negative $21.813 billion on 2026-02-28, down another $11.484 billion, and reached negative $23.686 billion in the latest annual period. Compared with the earliest period, the latest FCF is $23.324 billion more negative. This is the clearest negative financial trend in the dataset.
• Capital expenditures and investing: Capital expenditures rose from $8.502 billion to $20.535 billion, then $39.170 billion, and $55.663 billion in the latest period. Investing cash outflow expanded from $8.718 billion to $51.854 billion across the reported periods. Investment intensity is accelerating materially.
• Operating cash flow: Cash from operations increased from $8.140 billion to $10.206 billion, then $17.357 billion, and $31.977 billion. This is a strong upward trajectory, but it has not kept pace with the increase in capital expenditures, producing increasingly negative FCF.
• Liquidity and working capital: Current assets rose from $24.634 billion to $34.366 billion, $54.874 billion, then declined to $46.567 billion. Current liabilities moved from $39.874 billion to $37.795 billion, $40.737 billion, and $41.764 billion. Working capital improved from negative $15.240 billion to negative $3.429 billion, then positive $14.137 billion, before falling to positive $4.803 billion. The current ratio improved from 0.62 to 0.91, 1.35, then eased to 1.12.
• Cash balance: Cash and equivalents increased from $10.445 billion to $19.241 billion, then $38.455 billion, before declining to $31.289 billion. Latest cash remains $20.844 billion above the earliest reported level, but declined $7.166 billion from the prior period.
• Assets and equity: Total assets increased every period, from $180.449 billion to $204.984 billion, $245.240 billion, and $261.759 billion. Shareholders’ equity also rose from $24.154 billion to $29.951 billion, $38.495 billion, and $42.508 billion. Retained earnings improved from negative $14.054 billion to negative $4.309 billion, a cumulative improvement of $9.745 billion, though they remained negative in the latest period.
• Debt: Debt-to-equity data is unavailable, so leverage cannot be assessed comprehensively from the supplied balance sheet.

Financial Health

• The latest financial picture is mixed: revenue, operating income, operating cash flow, total assets, and equity all show strong growth, while FCF and liquidity have weakened from their immediately preceding levels.
• Operating performance appears resilient. Comparable quarterly operating income advanced from $4.277 billion to $5.464 billion, and operating margin expanded by 3.14 percentage points over that sequence.
• The principal financial risk is the scale and acceleration of investment spending. Latest reported capex of $55.663 billion exceeded operating cash flow of $31.977 billion by approximately $23.686 billion, matching the reported negative FCF.
• Liquidity is currently positive on a working-capital basis, with a 1.12 current ratio and $4.803 billion of working capital, but both measures deteriorated from 1.35 and $14.137 billion in the prior period.
• Cash remains substantial at $31.289 billion, yet it declined from $38.455 billion while investing outflows and capex expanded. Financing cash flow was strongly positive at $40.284 billion in the latest period, but the payload does not identify its components.
• No debt figures or debt maturities are supplied. Accordingly, the balance-sheet risk from financing the investment program cannot be fully quantified.
• Overall, the trend supports a business with improving operating profitability but a capital-intensive expansion profile that currently absorbs more cash than operations generate.

Insider Activity

• Insider sentiment for 2026-06-05 through 2026-09-03 was Neutral (-6).
• Insiders reported $16.432 million of purchases across 2 transactions versus $63.664 million of sales across 12 transactions.
• Net insider activity was negative $47.232 million, indicating substantially more reported selling than buying during the sentiment window.
• No Forms 4/5 insider filings were found for 2026-08-04 through 2026-09-03, so there is no very recent filing activity in the supplied data.
• Insider transactions are a secondary signal and do not establish the reason for the reported sales.

Multi-Timeframe Technical Context

• Ultra-short horizon — minutes: The 1-minute structure is mildly constructive. Price is above the 12-, 26-, and 50-period EMAs, with MACD at 0.0527 above its 0.0439 signal. RSI-14 is 52.1, suggesting neutral momentum. Price at $147.35 is near the upper Bollinger Band at $147.41. Volume is only 190 versus a 20-period average of approximately 1,467, so the immediate move lacks strong volume confirmation.
• Short horizon — hours to days: The 15-minute chart is also modestly positive: price is above the 12-, 26-, and 50-period EMAs, MACD is 0.2631 versus a 0.2569 signal, and RSI-14 is 54.59. However, the 200-bar move is still negative 1.47%, and current volume is below its 20-period average. The 1-hour chart is stronger but more extended: RSI-14 is 74.52 and RSI-21 is 76.47, both indicating overbought conditions, while MACD remains positive at 0.8149 versus 0.4856. This combination favors upside momentum but raises pullback risk.
• Longer horizon — weeks to months: The daily chart remains structurally damaged after a 200-bar decline of 30.87%. RSI-14 is 39.35, MACD is slightly below its signal, and price is below the 20-day SMA of $147.19 by a small amount while remaining above the 50-day SMA of $139.78. The weekly chart shows a 27.08% 145-bar gain but remains below its 12-, 26-, and 50-week EMAs and below the 20-week SMA of $163.85. Monthly momentum is also weak: RSI-14 is 37.21, MACD is 0.1109 versus a 9.6757 signal, and price is well below the 20-month SMA of $183.43.
• The multi-timeframe picture is therefore mixed: intraday momentum has improved sharply, but daily, weekly, and monthly trends remain below important moving-average structures.
• The provided daily and hourly current prices differ slightly from the stated current price: $145.75/$147.35 versus $147.39. This may reflect different timestamps or feeds.

Bull / Bear Cases

• Short-term bull case: Price is holding above short-term EMAs on both the 1-minute and 15-minute charts, with positive MACD readings and a 1-hour close above the 20-period SMA. A sustained move through the session high of $153.99 would indicate that buyers are overcoming the recent intraday range.
• Short-term bear case: The 1-hour RSI readings above 74 indicate an extended move, while 1-minute and 15-minute volume are below their respective averages. Failure to hold the $147 area could expose the stock to a retest of the session low at $137.43, particularly if the overbought hourly momentum reverses.
• Long-term bull case: Revenue and operating income are rising across comparable quarterly periods, operating margin improved from 28.65% to 31.79%, operating cash flow increased from $8.140 billion to $31.977 billion, and equity expanded from $24.154 billion to $42.508 billion. If the heavy investment program eventually produces sufficient operating cash returns, the improving operating trajectory could support a longer-term recovery.
• Long-term bear case: FCF deteriorated from negative $362 million to negative $23.686 billion, while capex rose to $55.663 billion. Cash declined by $7.166 billion from the prior period, working capital fell by $9.334 billion, and the stock remains below major weekly and monthly trend averages. Negative insider net activity and the absence of debt data add uncertainty to the long-term risk assessment.
• The central fundamental debate is whether accelerating investment is a productive growth phase or a prolonged drain on cash generation. The payload does not provide guidance, backlog, segment results, or return-on-investment data to resolve that question.

Key Levels & Triggers

…